P/E ratio for Alkem Laboratories (ALKEM.NS)
P/E ratio as of July 2025 (TTM): 23.9
According to Alkem Laboratories 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 23.8541. At the end of 2018 the company had a P/E ratio of 35.3.
P/E ratio history for Alkem Laboratories from 2015 to 2024
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2018 | 35.3 | -7.03% |
| 2017 | 38.0 | 64.09% |
| 2016 | 23.1 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.